215 related articles for article (PubMed ID: 34224153)
1. Generation of synthetic PET images of synaptic density and amyloid from
Wang R; Liu H; Toyonaga T; Shi L; Wu J; Onofrey JA; Tsai YJ; Naganawa M; Ma T; Liu Y; Chen MK; Mecca AP; O'Dell RS; van Dyck CH; Carson RE; Liu C
Med Phys; 2021 Sep; 48(9):5115-5129. PubMed ID: 34224153
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [
Chen MK; Mecca AP; Naganawa M; Gallezot JD; Toyonaga T; Mondal J; Finnema SJ; Lin SF; O'Dell RS; McDonald JW; Michalak HR; Vander Wyk B; Nabulsi NB; Huang Y; Arnsten AF; van Dyck CH; Carson RE
J Cereb Blood Flow Metab; 2021 Sep; 41(9):2395-2409. PubMed ID: 33757318
[TBL] [Abstract][Full Text] [Related]
3. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [
Vogler L; Ballweg A; Bohr B; Briel N; Wind K; Antons M; Kunze LH; Gnörich J; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Boening G; Ziegler SI; Levin J; Zwergal A; Höglinger GU; Herms J; Brendel M
Neuroimage Clin; 2023; 39():103484. PubMed ID: 37541098
[TBL] [Abstract][Full Text] [Related]
4. Deep learning generation of preclinical positron emission tomography (PET) images from low-count PET with task-based performance assessment.
Dutta K; Laforest R; Luo J; Jha AK; Shoghi KI
Med Phys; 2024 Jun; 51(6):4324-4339. PubMed ID: 38710222
[TBL] [Abstract][Full Text] [Related]
5. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
[TBL] [Abstract][Full Text] [Related]
6. Determination of optimal regularization factor in Bayesian penalized likelihood reconstruction of brain PET images using [
Wagatsuma K; Miwa K; Kamitaka Y; Koike E; Yamao T; Yoshii T; Kobayashi R; Nezu S; Sugamata Y; Miyaji N; Imabayashi E; Ishibashi K; Toyohara J; Ishii K
Med Phys; 2022 May; 49(5):2995-3005. PubMed ID: 35246870
[TBL] [Abstract][Full Text] [Related]
7. Noise reduction with cross-tracer and cross-protocol deep transfer learning for low-dose PET.
Liu H; Wu J; Lu W; Onofrey JA; Liu YH; Liu C
Phys Med Biol; 2020 Sep; 65(18):185006. PubMed ID: 32924973
[TBL] [Abstract][Full Text] [Related]
8. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.
Ng S; Villemagne VL; Berlangieri S; Lee ST; Cherk M; Gong SJ; Ackermann U; Saunder T; Tochon-Danguy H; Jones G; Smith C; O'Keefe G; Masters CL; Rowe CC
J Nucl Med; 2007 Apr; 48(4):547-52. PubMed ID: 17401090
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Synaptic Density Imaging with
Toyonaga T; Smith LM; Finnema SJ; Gallezot JD; Naganawa M; Bini J; Mulnix T; Cai Z; Ropchan J; Huang Y; Strittmatter SM; Carson RE
J Nucl Med; 2019 Dec; 60(12):1780-1786. PubMed ID: 31101744
[No Abstract] [Full Text] [Related]
10. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
11. Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [
O'Dell RS; Mecca AP; Chen MK; Naganawa M; Toyonaga T; Lu Y; Godek TA; Harris JE; Bartlett HH; Banks ER; Kominek VL; Zhao W; Nabulsi NB; Ropchan J; Ye Y; Vander Wyk BC; Huang Y; Arnsten AFT; Carson RE; van Dyck CH
Alzheimers Res Ther; 2021 Jan; 13(1):11. PubMed ID: 33402201
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis.
Fu L; Liu L; Zhang J; Xu B; Fan Y; Tian J
Eur Radiol; 2014 Nov; 24(11):2800-9. PubMed ID: 25097125
[TBL] [Abstract][Full Text] [Related]
13. Healthy brain aging assessed with [
Andersen KB; Hansen AK; Knudsen K; Schacht AC; Damholdt MF; Brooks DJ; Borghammer P
Nucl Med Biol; 2022; 112-113():52-58. PubMed ID: 35820300
[TBL] [Abstract][Full Text] [Related]
14. Generation of Whole-Body FDG Parametric
Miao T; Zhou B; Liu J; Guo X; Liu Q; Xie H; Chen X; Chen MK; Wu J; Carson RE; Liu C
IEEE Trans Radiat Plasma Med Sci; 2023 May; 7(5):465-472. PubMed ID: 37997577
[TBL] [Abstract][Full Text] [Related]
15. Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging.
Akamatsu G; Ikari Y; Nishio T; Nishida H; Ohnishi A; Aita K; Sasaki M; Sasaki M; Senda M
Ann Nucl Med; 2016 Jan; 30(1):18-28. PubMed ID: 26337533
[TBL] [Abstract][Full Text] [Related]
16. Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.
Tiepolt S; Hesse S; Patt M; Luthardt J; Schroeter ML; Hoffmann KT; Weise D; Gertz HJ; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1700-9. PubMed ID: 27026271
[TBL] [Abstract][Full Text] [Related]
17. Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks.
Zaker N; Haddad K; Faghihi R; Arabi H; Zaidi H
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4048-4063. PubMed ID: 35716176
[TBL] [Abstract][Full Text] [Related]
18. Tracer-specific reference tissues selection improves detection of
Li Y; Ng YL; Paranjpe MD; Ge Q; Gu F; Li P; Yan S; Lu J; Wang X; Zhou Y;
Hum Brain Mapp; 2022 May; 43(7):2121-2133. PubMed ID: 35165964
[TBL] [Abstract][Full Text] [Related]
19. Generation of Conventional
Choi HJ; Seo M; Kim A; Park SH
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512092
[No Abstract] [Full Text] [Related]
20. Evaluation of early-phase [
Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
